High-volume Yet Low-value Sales Projected in Benzodiazepine Drugs Market

With a multi-disciplinary approach, Fact.MR elaborates an extensive
analysis of the historical, current and future outlook of the global
benzodiazepine drugs market as well as the factors responsible for such a
growth. Our highly dedicated professionals have inputted critical and
accurate insights associated with every industry, and region by doing
thorough primary and secondary research.

Benzodiazepine drugs are
medications which are commonly used to treat lifestyle based ailments
such as chronic back pain, insomnia, and anxiety. These are a type of
psychoactive drugs, which comprise a fusion of diazepine and benzene
rings. Benzodiazepine drugs are widely considered to be short and
intermediate term drugs for the treatment of anxiety.

The global
benzodiazepine market is expected to witness a sluggish CAGR of 2.7 per
cent through the end of the forecast period in 2026. However, while
benzodiazepines are expected to witness a demand for high volumes of
these drugs, the contribution of such sales will remain moderate in
value in terms of market share.

We leverage space-age industrial
and digitalization tools to provide avant-garde actionable insights to
our clients regarding the benzodiazepine drugs market. For enhancing
readers’ experience, the report starts with a basic overview about the
benzodiazepine drugs market and its classification. Further, we have
considered 2018 as the base year, 2019 as the estimated year, 2019 – 2029 as the stipulated timeframe.

Competitive Assessment

The benzodiazepine drugs market report includes global as well as emerging players:

• Pfizer Inc.
• Hoffmann-La Roche Ltd.
• Bausch Health Companies, Inc.
• Mylan N.V.
• Teva Pharmaceutical Industries Ltd.
• Lundbeck A/S
• Amneal Pharmaceuticals LLC
• Sun Pharmaceutical Industries Ltd.
• Apotex Inc.
• Aurobindo Pharma

The insights for each vendor consists of:

• Company profile
• SWOT analysis
• Main market information
• Market share
• Revenue, pricing and gross margin

Regional Analysis

Important regions covered in the benzodiazepine drugs market report include:

• North America
• Europe
• Asia Pacific
• Latin America
• MEA

Generic Products to Maintain Rise

North
America is set to become the key contributor to the benzodiazepine
drugs market, owing to the high rates of consumption for the treatment
of anxiety disorders in this region, as anxiety ailments affect around
40 million adults in the United States alone, for every year.

Benzodiazepine
drugs are primarily used for anxiety issues, and this accounts for more
than 50 per cent of the overall sales figures. This trend is expected
to contribute towards increasing adoption rates, even as the
consciousness among patients for treatment options increases.

On
the other hand, despite the high scope of use, the increasingly strict
regulations set by governments with the aim of stopping drug abuse, has
restricted benzodiazepine drugs sales as they are limited to retail
outlets and pharmacies, with sales only made possible with legal
prescriptions. Following North America, the Latin America and Asia
Pacific markets are expected to display moderate rates of growth for the
foreseeable future.

Further branded medications are continuing to
witness diminishing returns owing to the rising popularity of generic
variants. The high capital needs for the development of high quality
standards for branded drugs, are also bolstering the penetration for
generic drugs in the benzodiazepine industry.

The benzodiazepine drugs market report also provides data regarding the key countries in the defined regions.

Segmentation Analysis

By Product:

• Alprazolam
• Clonazepam
• Diazepam
• Lorazepam

By Application:

• Anxiety
• Insomnia
• Alcohol Withdrawal
• Seizures

What insights does the benzodiazepine drugs market report provide to the readers?

• Benzodiazepine drugs market fragmentation on the basis of product type, end use, and region.
• Comprehensive assessment of upstream starting materials, downstream demand, and present market landscape.
• Collaborations, R&D projects, acquisitions, and product launches of each benzodiazepine drugs market player.
• Various regulations imposed by the governments on the consumption of benzodiazepine drugs market in detail.
• Impact
  of modern technologies, such as big data & analytics, artificial
  intelligence, and social media platforms on the global benzodiazepine
  drugs market.

Deaths and Side Effects from Drug Abuse are Key Restraints for Industry

While
benzodiazepine is fairly common drug, an increasing number of factors
in recent years have resulted in restricted growth of the market. Some
of the major restraints in the industry, is the abuse of these drugs by
patients and a number of cases involving overdoses, which have even led
to death.

In addition, while short and intermediate terms of
consumption of benzodiazepine have been found to be beneficial for
patients, long term use can result in a number of side effects, some of
which are severe in nature. These can include dizziness, breathing
difficulties, tremors, weakness, pneumonia, brain damage, and in extreme
cases, even death.

Consequently, a number of governments around
the world have set up measures to maintain oversight over relevant
prescriptions, which are expected to hamper the growth of the market
through the forecast period.

In addition, the number of outpatient
visits have increased, which have ultimately led to a prescription of
benzodiazepine has shot up. Women are more likely to get the
prescriptions for these medications, as this demographic is more likely
to be one of the medications to reach into.

Questionnaire answered in the benzodiazepine drugs market report include:

• How the market for benzodiazepine drugs market has grown over the historic period of 2014-2018?
• What is the present and future outlook of the global benzodiazepine drugs market on the basis of region?
• What are the challenges and opportunities for the benzodiazepine drugs market?
• Why the consumption of benzodiazepine drugs market highest in region?
• In which year segment is expected to overtake segment?

Contact:

Unit No: AU-01-H Gold Tower (AU), Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers, Dubai, United Arab Emirates
MARKET ACCESS DMCC Initiative
Email: sales@factmr.com
Web: https://www.factmr.com/
Blog - https://blog.factmr.com/